Gene · 2213
Papers4,232
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 4,232
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cellular Components of the Tumor Environment in Gliomas-What Do We Know Today? | Biomedicines | 2023 | 38275375 | PubTator, text mining | PubMed |
| IgG in the control of FcεRI activation: a battle on multiple fronts. | Front Immunol | 2023 | 38274816 | PubTator, text mining | PubMed |
| Defining genetic diversity of rhesus macaque Fcγ receptors with long-read RNA sequencing. | Front Immunol | 2023 | 38264644 | PubTator, text mining | PubMed |
| Impact of structural modifications of IgG antibodies on effector functions. | Front Immunol | 2023 | 38259472 | PubTator, text mining | PubMed |
| Evaluation of the safety, efficacy, and mechanism of action of obexelimab for the treatment of patients with IgG4-related disease: an open-label, single-arm, single centre, phase 2 pilot trial. | Lancet Rheumatol | 2023 | 38251576 | PubTator, text mining | PubMed |
| A glycoengineered therapeutic anti-HBV antibody that allows increased HBsAg immunoclearance improves HBV suppression in vivo. | Front Pharmacol | 2023 | 38205373 | PubTator, text mining | PubMed |
| Novel HER-2 Targeted Therapies in Breast Cancer. | Cancers (Basel) | 2023 | 38201515 | PubTator, text mining | PubMed |
| The Acquisition of Complement-Dependent Cytotoxicity by the Type II Anti-CD20 Therapeutic Antibody Obinutuzumab. | Cancers (Basel) | 2023 | 38201478 | PubTator, text mining | PubMed |
| Insights into the Structure, Metabolism, Biological Functions and Molecular Mechanisms of Sialic Acid: A Review. | Foods | 2023 | 38201173 | PubTator, text mining | PubMed |
| Th1-related transcription factors and cytokines in systemic lupus erythematosus. | Front Immunol | 2023 | 38164134 | PubTator, text mining | PubMed |
| Antibodies as clinical tools for tuberculosis. | Front Immunol | 2023 | 38162666 | PubTator, text mining | PubMed |
| Recent Advances in the Development of Monoclonal Antibodies and Next-Generation Antibodies. | Immunohorizons | 2023 | 38149884 | PubTator, text mining | PubMed |
| Virus-Host Protein Interaction Network of the Hepatitis E Virus ORF2-4 by Mammalian Two-Hybrid Assays. | Viruses | 2023 | 38140653 | PubTator, text mining | PubMed |
| Successful Allergen-Specific Immunotherapy: Induction of Unresponsiveness by 'Vaccination'. | Vaccines (Basel) | 2023 | 38140255 | PubTator, text mining | PubMed |
| Delving into Molecular Pathways: Analyzing the Mechanisms of Action of Monoclonal Antibodies Integrated in IMGT/mAb-DB for Myasthenia Gravis. | Vaccines (Basel) | 2023 | 38140161 | PubTator, text mining | PubMed |
Increased CD16a (FcγRIIIA) Expression in The Tumor Microenvironment of Atypical Neurofibromatous Neoplasms of Uncertain Biologic Potential May Be Associated with Progression from Neurofibromas to Atypical Neurofibromas. | J Pers Med | 2023 | 38138947 | PubTator, text mining | PubMed |
| The Prognosis Performance of a Neutrophil- and Lymphocyte-Associated Gene Mutation Score in a Head and Neck Cancer Cohort. | Biomedicines | 2023 | 38137334 | PubTator, text mining | PubMed |
| The Therapeutic Monoclonal Antibody Bamlanivimab Does Not Enhance SARS-CoV-2 Infection by FcR-Mediated Mechanisms. | Pathogens | 2023 | 38133292 | PubTator, text mining | PubMed |
| The B Cell Response and Formation of Allergenic and Anti-Allergenic Antibodies in Food Allergy. | Biology (Basel) | 2023 | 38132327 | PubTator, text mining | PubMed |
| Therapeutic Monoclonal Antibodies against Cancer: Present and Future. | Cells | 2023 | 38132155 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2213/papers?page=13